SCHEMBL14974666

SCHEMBL14974666

CC(S(=O)(=O)O)S(=O)(=O)O.[NaH]

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
TSHR P16473 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
NT5E P21589 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17510158 1.00 CA5A (0.36) CA5ACA5BTSHRCA1CA2
SCHEMBL23269 0.96 CA5A (0.39) CA5ACA5BTSHRCA1CA2
SCHEMBL27433721 0.96 CA5A (0.39) CA5ACA5BTSHRCA1CA2
SCHEMBL2571875 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
Water SCHEMBL1614964 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
Water SCHEMBL384922 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
Ammonia Solution, Strong SCHEMBL5760496 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
SCHEMBL29170918 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
SCHEMBL16756653 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2
Hydrochloric Acid SCHEMBL27895967 0.92 CA5A (0.36) CA5ACA5BTSHRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12129239-B2 Method for producing methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2024-10-29 US disclosed
EP-4006020-B1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2024-09-25 EP disclosed
CN-114144407-B Process for producing cyclic disulfonate compound 住友精化株式会社 2024-02-13 CN disclosed
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2023-10-31 US disclosed
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 US disclosed
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 US disclosed
CN-114728875-A Metal salts and their use 因思博纳公司 2022-07-08 CN disclosed
EP-4006020-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 EP disclosed
EP-4006019-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 EP disclosed
CN-114144407-A Process for producing cyclic disulfonate compound 住友精化株式会社 2022-03-04 CN disclosed
CN-114144406-A Method for producing methylene disulfonate compound 住友精化株式会社 2022-03-04 CN disclosed
CN-110983315-A Aqueous metal surface treatment agent, metal surface treatment film, and metal material having metal surface treatment film 日本帕卡濑精株式会社 2020-04-10 CN disclosed
CN-110698419-A Preparation method of cycleanine 广州康瑞泰药业有限公司 2020-01-17 CN disclosed
EP-2610250-B1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2016-01-20 EP disclosed
US-8501966-B2 Method for producing a methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-08-06 US disclosed
EP-2610250-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co. Ltd. (JP) 2013-07-03 EP disclosed
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129239-B2 Method for producing methylene disulfonate compound TST, MPST, SQOR CA5A 1410/4885CA5B 886/4885TSHR 3410/4885
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND STS, TST, SCLY CA5A 862/4885CA5B 932/4885TSHR 3098/4885
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND TST, MPST, SQOR CA5A 1410/4885CA5B 886/4885TSHR 3410/4885
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND DHPS, ADH7, MPST CA5A 153/4885CA5B 102/4885TSHR 3797/4885
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound STS, TST, SCLY CA5A 862/4885CA5B 932/4885TSHR 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.